MedTrace Logo

Non-Interventional Study PREVENT

NCT02155998 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-04-11

No results posted yet for this study

Summary

This is a multicentre, non-interventional, prospective study to be carried out in representative medical institutions in order to get the information on administration of postoperative and post-radiation adjuvant androgen deprivation therapy (including "go" / "no go" decision, regimens, dosages and duration) used in locally advanced prostate cancer patients with high and very high risk of recurrence in Russia.

Conditions

  • Postoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) Patients

Sponsors & Collaborators

Principal Investigators

  • Karin Otter · AstraZeneca

  • Boris Alexeev · Moscow Research Institute of Oncology named after PA Herzen

  • Vsevolod Matveev · Russian Cancer Research Center named after NN Blokhin

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-16
Primary Completion
2016-12-14
Completion
2016-12-14

Countries

  • Russia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02155998 on ClinicalTrials.gov